ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "Measurement Instrument"

  • Abstract Number: 0549 • ACR Convergence 2023

    Development of Customized Digital Cognitive Assessment Battery: A Pilot Use Case in SLE Patients

    Priyanka Srivastava1 and Liza Rajasekhar2, 1International Institute of Information Technology, Hyderabad, India, 2Nizam's Institute of Medical Sciences, Madhapur, India

    Background/Purpose: Reported prevalence of cognitive dysfunction (CD) in SLE varies from 3%-88%1.Variability may be due to use of tools insensitive to population characteristics like literacy,…
  • Abstract Number: 0581 • ACR Convergence 2023

    Performance Characteristics of a Novel, Fully Automated Multiplexed Immunoassay Microarray Prototype for the Serological Detection of Eleven IgG Autoantibodies Commonly Found in Connective Tissue Diseases

    Daphne Bijlsma, Ewa Lukasik, Michael Hausmann, Gerber Gomez, Christine Ginocchio and Emmanuel Moreau, Quotient Suisse SA, Eysins, Switzerland

    Background/Purpose: Detection of autoantibodies is key for the identification and prognosis of patients with connective tissue diseases (CTD); however, some current testing methods are manual,…
  • Abstract Number: 0613 • ACR Convergence 2023

    Quantification of Skin Hardness of Patients with Systemic Sclerosis Using SOFTGRAM

    Hiraku Kokubu1, Yasuaki Ikuno1, Kazuyuki Uchiyama1, Miwa Kato1, Mayuka Yamamoto1, Haruki Asada1, Satona Rikitake1, Yoshimichi Kobayashi1, Takahiro Koike1, Syuji Sugiura1, Takuma Hayami1, Kensuke Yoneta1, Toshifumi Takahashi1, Bunpei Yamamoto1, Takeshi Kato1, Yoshito Kunisaki2, Makoto Nakatani2, Kohei Okamoto2 and Noriki Fujimoto1, 1Shiga University of Medical Science, Otsu, Japan, 2ISHIDA MEDICAL CO.,LTD., Kyoto, Japan

    Background/Purpose: No quantitative and objective methods for measuring skin hardness have been established. Japanese technology leads the world in the tactile sensor field, and SOFTGRAM…
  • Abstract Number: 0622 • ACR Convergence 2023

    The Effectiveness of Breath-holding Test to Predict Pulmonary Function in Systemic Sclerosis Patients Using Machine Learning Model

    Jina Yeo1, Min Hyuk Lim2, Ju Yeon Kim3, Ji In Jung4, Saram Lee2 and Eun Bong Lee3, 1Division of Rheumatology, Department of Internal Medicine, Gachon University Gil Medical Center, Incheon, South Korea, 2Department of Transdisciplinary Medicine, Seoul National University Hospital, Seoul, South Korea, 3Seoul National University Hospital, Seoul, South Korea, 4Division of Rheumatology, Department of Internal Medicine, Seoul National University Hospital, Seoul, South Korea

    Background/Purpose: Pulmonary involvement is major causes of mortality in patients with systemic sclerosis (SSc). The breath-holding test (BHT), rapid bedside test, is a useful surrogate…
  • Abstract Number: 0745 • ACR Convergence 2023

    Artificial Intelligence Models for Computer-Assisted Joint Detection and Sharp-van Der Heijde Score Prediction in Hand Radiographs from Patients with Rheumatoid Arthritis

    Carol Hitchon1, Saqib Al Islam1, Daryl LX Fung1, Qian Liu1, Leann Lac1, Susan Bartlett2, Louis Bessette3, Gilles Boire4, Vivian Bykerk5, Glen Hazlewood6, Edward Keystone7, Janet Pope8, Orit Schieir9, Carter Thorne10, Diane Tin11, Marie-France Valois12, Désirée van der Heijde13, Canadian Early Arthritis Cohort (CATCH) Investigators14, Liam O'Neil1 and Pingzhao Hu15, 1University of Manitoba, Winnipeg, MB, Canada, 2McGill University, Montreal, QC, Canada, 3Centre de l'Ostéoporose et de Rhumatologie de Québec, Quebec City, QC, Canada, 4Université de Sherbrooke, Sherbrooke, QC, Canada, 5Hospital for Special Surgery, New York, NY, 6University of Calgary, Calgary, AB, Canada, 7Keystone Consulting Enterprises Inc., Toronto, ON, Canada, 8University of Western Ontario, London, ON, Canada, 9McGill University, Montréal, QC, Canada, 10Southlake Regional Health Centre, Newmarket, ON, Canada, 11The Arthritis Program Research Group, Newmarket, ON, Canada, 12McGill University, Pointe-Claire, QC, Canada, 13Department of Rheumatology, Leiden University Medical Center, Leiden, Netherlands, 14CATCH, Winnipeg, MB, Canada, 15Western University, London, ON, Canada

    Background/Purpose: Radiographs are used to detect and monitor joint damage due to rheumatoid arthritis (RA).Scoring methods such as the Sharp van der Heijde tool (SVH)…
  • Abstract Number: 1218 • ACR Convergence 2023

    Discovering the Potential Application of Digital Biomarkers for Inflammatory Arthritis Patients, a Design Thinking Approach; Preliminary Results of the Patients’ Perspective

    patty de Groot1, ilja Tchetverikov2, Yvonne P. M. Goekoop-Ruiterman3, Wendy Olsder4, Rien Bakker5, Marc r. Kok6, Jasper Foolen7 and Jolanda J. Luime1, 1Erasmus Medical Center, Rotterdam, Netherlands, 2Albert Sweitzer Hospital, Dordrecht, Netherlands, 3Haga Ziekenhuis, The Hague, Netherlands, 4Erasmus School of Health Policy and Management, Rotterdam, Netherlands, 5Consortium Beroepsonderwijs, Information Communication Technology, Amersfoort, Netherlands, 6Maasstad Hospital, Rotterdam, Netherlands, 7Eindhoven University of Technology deparment of Biomedical Engineering, Eindhoven, Netherlands

    Background/Purpose: The Inflammatory Arthritis (IA) patient population is growing, whilst facing a shortage of health care professionals (HCPs). It is impossible to meet the future…
  • Abstract Number: 1894 • ACR Convergence 2023

    3-Dimensional Regional Variation in Inter-rater Reliability of Bone Marrow Lesion Scoring in the Knee

    Stephanie Wichuk1, Walter P. Maksymowych1, Joel Paschke2, Abhilash Hareendranathan3 and Jacob Jaremko1, 1University of Alberta, Edmonton, AB, Canada, 2CARE Arthritis, Edmonton, AB, Canada, 3Radiology and Diagnostic Imaging, Edmonton, AB, Canada

    Background/Purpose: Bone marrow lesions (BML) are an important scoring feature on magnetic resonance imaging (MRI) of knee osteoarthritis (OA), and their presence in certain anatomical…
  • Abstract Number: 1902 • ACR Convergence 2023

    Improving the Sharing of Information from Reviews of Measurement Properties: The OMERACT Summary of Measurement Properties (SOMP) Table

    shawna grosskleg1, lara maxwell2, Dorcas Beaton3, B Shea1 and Peter Tugwell1, 1OMERACT, Ottawa, ON, Canada, 2University of Ottawa, Ottawa, ON, Canada, 3Institute for Work & Health, Toronto, ON, Canada

    Background/Purpose: Systematic reviews of measurement properties of an outcome measurement instrument are fast becoming the evidence base for making decisions about the suitability of the…
  • Abstract Number: 1907 • ACR Convergence 2023

    Selection of a Candidate Instrument to Assess Flare in Osteoarthritis with Content Matching with Endorsed Domains

    Fabiana Queiroga1, Marita Cross2, Lara Maxwell3, Leigh Callahan4, sam michel Cembalo5, Thomas Buttel2, Cindy Copenhaver6, Jonathan Epstein7, david Hunter8, Lauren King9, Lyn March2 and Francis Guillemin10, 1Université de Lorraine, Antibes, France, 2University of Sydney, Sydney, Australia, 3OMERACT, Ottawa, ON, Canada, 4The University of North Carolina, Chapel Hill, NC, 5OMERACT, Nancy, France, 6OMERACT, Chapel Hill, NC, 7Université de Lorraine, Nancy, France, 8Sydney Musculoskeletal Health, University of Sydney, St. Leonards, Australia, 9Clinical Associate, Division of Rheumatology, St. Michael’s Hospital, Toronto, ON, Canada, 10Université de Lorraine, EA 4360 Apemac, Nancy, France

    Background/Purpose: The Outcome Measures in Rheumatology group (OMERACT) developed methodological steps to select instrument(s) to assess content appropriateness of outcomes, as well as tools to…
  • Abstract Number: 1995 • ACR Convergence 2023

    Cross-cultural Adaptation, Reduction, and Validation of the Turkish Versions of the Flare-OA Questionnaire for Hip and Knee Osteoarthritis

    Mehmet Tuncay Duruöz1, Halise Hande Gezer1, Jonathan Epstein2, Marc Soudant2 and Francis Guillemin3, 1Marmara University Medical School PMR Department, Rheumatology Division, Istanbul, Turkey, 2Université de Lorraine, Epidémiologie clinique, Nancy, France, 3Université de Lorraine, EA 4360 Apemac, Nancy, France

    Background/Purpose: The Flare-OA is a recently developed self-reported questionnaire to assess the occurrence and severity of flares in knee and hip osteoarthritis (OA). It evaluates…
  • Abstract Number: 2023 • ACR Convergence 2023

    Transition Readiness over Time in a Rheumatology Transition Clinic

    Background/Purpose: In 2018 we designed a Rheumatology Transition clinic to care for adolescent patients with autoimmune disease. We incorporate Health Care Transition curriculum (HCT) into…
  • Abstract Number: 2067 • ACR Convergence 2023

    A New Tool Assessing Trainees’ Interventional Musculoskeletal Ultrasound Skills

    Stine Maya Dreier Carstensen1, Lene Terslev2, Søren Just3, Mikkel Østergaard4, Mogens Pfeiffer-Jensen1 and Lars Konge5, 1Copenhagen Center for Arthritis Research, Center for Rheumatology and Spine Diseases, Centre for Head and Orthopaedics, Copenhagen University Hospital – Rigshospitalet Glostrup, Copenhagen, Denmark, 2Center for Rheumatology and Spine Diseases, Rigshospitalet, Glostrup, Denmark, 3Section of Rheumatology, Department of Medicine, Odense University Hospital – Svendborg Hospital, Odense, Denmark, 4Copenhagen Center for Arthritis Research, Center for Rheumatology and Spine Diseases, Centre for Head and Orthopaedics, Rigshospitalet; University of Copenhagen, Copenhagen, Denmark, 5Copenhagen Academy for Medical Education and Simulation The Capital Region of Denmark, Copenhagen, Denmark

    Background/Purpose: Interventional musculoskeletal ultrasound (MSUS) procedures, such as ultrasound-guided arthrocentesis and joint injections, are routinely used in rheumatology practice. However, the efficacy and safety of…
  • Abstract Number: 0157 • ACR Convergence 2023

    Discovering the Potential of Digital Biomarkers in the Work Process of the Rheumatology Healthcare Professionals, a Design Thinking Approach; Preliminary Results of the Healthcare Professionals Perspective

    patty de Groot1, Jolanda J. Luime1, Marc r. Kok2, marijn vis1 and ilja Tchetverikov3, 1Erasmus Medical Center, Rotterdam, Netherlands, 2Maasstad Hospital, Rotterdam, Netherlands, 3Albert Sweitzer Hospital, Dordrecht, Netherlands

    Background/Purpose: During times of social-distancing, in-person outpatient visits were greatly reduced. Health care professionals (HCPs) were dependent on the patient's reported experience of their disease…
  • Abstract Number: 0190 • ACR Convergence 2023

    Racial Disparities in Self-reported Extent and Reasons for Nonadherence in SLE

    Kai Sun1, Londyn Robinson2, Amanda Eudy3, Jennifer Rogers1, Rebecca Sadun1, Lisa Criscione-Schreiber4, Jayanth Doss1 and Megan Clowse5, 1Duke University, Durham, NC, 2University of Minnesota Medical School, Minneapolis, MN, 3Duke University, Raleigh, NC, 4Duke University School of Medicine, Durham, NC, 5Duke University, Chapel Hill, NC

    Background/Purpose: Medication nonadherence is common in SLE and disproportionately affects Black patients. Nonadherence leads to increased hospitalizations, morbidity, and mortality and is a modifiable factor…
  • Abstract Number: 0300 • ACR Convergence 2023

    Nailfold Videocapillaroscopy in Idiopathic Inflammatory Myopathy Compared with Healthy Controls

    Megan Sullivan1, Maximiliano Diaz-Menindez2, Colleen T. Ball2, Benjamin Wang3 and Florentina Berianu1, 1Mayo Clinic Florida, Jacksonville, FL, 2Mayo Clinic Jacksonville, Jacksonville, FL, 3Mayo Clinic, Jacksonville, FL

    Background/Purpose: Idiopathic inflammatory myopathies (IIMs) are a group of autoimmune disorders that cause inflammation of the muscle. This includes dermatomyositis and polymyositis. Literature has been…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • 5
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology